Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model.

Xue H, Wang Y, MacCormack TJ, Lutes T, Rice C, Davey M, Dugourd D, Ilenchuk TT, Stewart JM.

J Cancer. 2018 Aug 6;9(17):3196-3207. doi: 10.7150/jca.20639. eCollection 2018.

2.

Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.

Fu S, Hirte H, Welch S, Ilenchuk TT, Lutes T, Rice C, Fields N, Nemet A, Dugourd D, Piha-Paul S, Subbiah V, Liu L, Gong J, Hong D, Stewart JM.

Invest New Drugs. 2017 Jun;35(3):397. doi: 10.1007/s10637-017-0455-y. No abstract available.

3.

First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.

Fu S, Hirte H, Welch S, Ilenchuk TT, Lutes T, Rice C, Fields N, Nemet A, Dugourd D, Piha-Paul S, Subbiah V, Liu L, Gong J, Hong D, Stewart JM.

Invest New Drugs. 2017 Jun;35(3):324-333. doi: 10.1007/s10637-017-0438-z. Epub 2017 Feb 1. Erratum in: Invest New Drugs. 2017 Jun;35(3):397.

4.

Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

Dugourd D, Yang H, Elliott M, Siu R, Clement JJ, Straus SK, Hancock RE, Rubinchik E.

Antimicrob Agents Chemother. 2011 Aug;55(8):3720-8. doi: 10.1128/AAC.00322-11. Epub 2011 May 16.

5.

Mechanism of action and limited cross-resistance of new lipopeptide MX-2401.

Rubinchik E, Schneider T, Elliott M, Scott WR, Pan J, Anklin C, Yang H, Dugourd D, Müller A, Gries K, Straus SK, Sahl HG, Hancock RE.

Antimicrob Agents Chemother. 2011 Jun;55(6):2743-54. doi: 10.1128/AAC.00170-11. Epub 2011 Apr 4.

6.

Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.

Rubinchik E, Dugourd D, Algara T, Pasetka C, Friedland HD.

Int J Antimicrob Agents. 2009 Nov;34(5):457-61. doi: 10.1016/j.ijantimicag.2009.05.003. Epub 2009 Jun 12.

PMID:
19524411
7.

Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides.

Melo MN, Dugourd D, Castanho MA.

Recent Pat Antiinfect Drug Discov. 2006 Jun;1(2):201-7. Review.

PMID:
18221145
8.

Semisynthetic approaches to laspartomycin analogues.

Curran WV, Leese RA, Jarolmen H, Borders DB, Dugourd D, Chen Y, Cameron DR.

J Nat Prod. 2007 Mar;70(3):447-50. Epub 2007 Feb 27.

PMID:
17323996
9.
10.

Characterization of a periplasmic ATP-binding cassette iron import system of Brachyspira (Serpulina) hyodysenteriae.

Dugourd D, Martin C, Rioux CR, Jacques M, Harel J.

J Bacteriol. 1999 Nov;181(22):6948-57.

11.

Genomic relatedness among Actinobacillus pleuropneumoniae field strains of sterotypes 1 and 5 isolated from healthy and diseased pigs.

Chatellier S, Harel J, Dugourd D, Chevallier B, Kobisch M, Gottschalk M.

Can J Vet Res. 1999 Jul;63(3):170-6.

12.

Chromosome sizes and phylogenetic relationships between serotypes of Actinobacillus pleuropneumoniae.

Chevallier B, Dugourd D, Tarasiuk K, Harel J, Gottschalk M, Kobisch M, Frey J.

FEMS Microbiol Lett. 1998 Mar 15;160(2):209-16.

13.

Cloning and characterization of a dextranase gene (dexS) from Streptococcus suis.

Serhir B, Dugourd D, Jacques M, Higgins R, Harel J.

Gene. 1997 May 6;190(2):257-61.

PMID:
9197542
14.

Characterization of Serpulina hyodysenteriae isolates of serotypes 8 and 9 by random amplification of polymorphic DNA analysis.

Dugourd D, Jacques M, Bigras-Poulin M, Harel J.

Vet Microbiol. 1996 Feb;48(3-4):305-14.

PMID:
9054126
15.

Localization of conserved B-cell epitopes among encapsulated and non-encapsulated Haemophilus influenzae P2 porin proteins using synthetic peptides.

Hamel J, Dugourd D, Martin D, Proulx C, Chong P, Brodeur BR.

J Gen Microbiol. 1992 Jan;138(1):161-8.

PMID:
1372928

Supplemental Content

Loading ...
Support Center